+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Urinary Tract Obstruction Treatment Devices Market by Device Technology, Treatment Modality, Patient Demographics, Obstruction Etiology, Intervention Setting, Approval Status, Innovation Trends, Distribution Channels, Cost Analysis, Clinical Evidence - Global Forecast to 2030- Product Image
Urinary Tract Obstruction Treatment Devices Market by Device Technology, Treatment Modality, Patient Demographics, Obstruction Etiology, Intervention Setting, Approval Status, Innovation Trends, Distribution Channels, Cost Analysis, Clinical Evidence - Global Forecast to 2030- Product Image
Sale

Urinary Tract Obstruction Treatment Devices Market by Device Technology, Treatment Modality, Patient Demographics, Obstruction Etiology, Intervention Setting, Approval Status, Innovation Trends, Distribution Channels, Cost Analysis, Clinical Evidence - Global Forecast to 2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6158633
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The field of urinary tract obstruction treatment devices has witnessed rapid evolution over the past decade, driven by technological breakthroughs and shifting clinical demands. In the wake of aging populations and rising prevalence of obstructive uropathies, stakeholders are under increasing pressure to deliver solutions that balance efficacy, patient comfort, and cost efficiency. Today’s decision-makers must navigate a complex interplay of device technologies, regulatory landscapes, and market dynamics. This executive summary equips industry leaders with a concise yet thorough overview of emerging trends, key challenges, and advisory insights-helping you stay ahead in a fast-moving environment where innovation and strategic foresight have never been more critical.

Transformative Shifts in the Urinary Tract Obstruction Treatment Landscape

Over the last few years, minimally invasive solutions have shifted from niche offerings to frontline therapies, propelled by the integration of advanced materials and digital assistance. Customized device solutions are no longer merely bespoke luxuries-they represent scalable approaches that harness nanomaterial applications and biodegradable coatings to optimize patient outcomes. Meanwhile, endoscopic procedures augmented by laser ablation have gained traction over open surgery, reducing recovery times and hospital stays. The rise of artificial intelligence assistance in digital integration is reshaping diagnostics and intraoperative guidance, while robotic assistance continues to expand procedural precision.

Conservative management within non surgical procedures has also evolved: adjunctive therapies like acoustic wave therapy and pharmacologic stents are redefining standard of care. High-risk seniors are driving demand for tailored interventions, and outpatient ambulatory care settings are increasingly favored to alleviate inpatient burdens. Together, these shifts underscore a transformative era where cross-disciplinary innovation and patient-centric design converge to set new benchmarks for safety, efficiency, and cost effectiveness.

Cumulative Impact of United States Tariffs Implemented in 2025

The implementation of tariffs on medical devices imported into the United States in early 2025 has created both headwinds and strategic inflection points. Manufacturers reliant on overseas components and finished goods have faced increased input costs, compelling many to reevaluate supply chains and accelerate localization efforts. For instance, premium options featuring advanced imaging integration have seen margin compression, prompting some firms to pivot toward cost effective solutions and value based models that balance quality with affordability.

Moreover, pending approval devices undergoing clinical trials now face heightened pressure to optimize development budgets and streamline regulatory submissions. Companies with manufacturing footprints in high-tariff regions have accelerated investment in domestic facilities or explored partnerships with U.S. contract manufacturers. At the same time, innovative materials providers are expanding U.S.-based pilot lines for nanomaterial applications, ensuring continuity of supply for biodegradable coatings. These adjustments have fostered a more resilient ecosystem, albeit one that demands greater agility and capital allocation strategies designed to mitigate trade-policy volatility.

Key Segmentation Insights Across Technology, Modality, and Patient Profiles

Market segmentation reveals nuanced growth drivers across diverse domains of obstruction treatment. Within device technology, minimally invasive solutions-such as laser-enabled stents-are redefining outpatient care, while innovative materials including biodegradable coatings and nanomaterial applications enhance biocompatibility and reduce infection risk. Customized device solutions, meanwhile, enable precision fitting and optimization for challenging anatomies. When examining treatment modality, surgical methods led by endoscopic procedures and laser ablation are displacing traditional open surgeries, and conservative management protocols within non surgical procedures are gaining preference for low-risk patients, complementing adjunctive therapies that improve patient comfort.

Considering patient demographics reveals a tripartite focus: adult treatments account for baseline demand, pediatric treatments spur development of miniaturized instruments, and high-risk seniors require specialized high-safety devices. Obstruction etiology further informs device design, as benign prostatic hyperplasia dominates the male segment while calculi induced obstruction and secondary malignancies drive demand for flexible ureteroscopes and precision-guided ablation technologies. Intervention setting analysis highlights the ascendancy of outpatient procedures-particularly ambulatory care-reducing inpatient costs and hospital resource utilization, while emergency interventions and inpatient procedures continue to support critical and complex cases.

Approval status segmentation underscores a dynamic pipeline: approved devices form the commercial backbone, clinical trials illuminate emerging modalities, and pending approval innovations-particularly those leveraging digital integration with artificial intelligence assistance-promise to reshape diagnostic accuracy and procedural guidance. Distribution channels are diversifying beyond traditional hospital networks to include e-commerce platforms offering direct-to-consumer devices, and retail clinics that enhance accessibility. Finally, cost analysis stresses the balance between cost effective solutions for mass markets, premium options for specialized applications, and value based solutions catering to budget-sensitive providers through budget friendly innovations. In terms of clinical evidence, longitudinal studies emerging from meta analyses bolster confidence in randomized control trials and observational studies, reinforcing the efficacy of advanced obstruction treatments.

Key Regional Insights Shaping Market Dynamics

Regional dynamics continue to shape competitive strategies and growth trajectories. In the Americas, established healthcare systems and robust reimbursement frameworks support rapid adoption of premium options-particularly in major hospital networks-while emerging value based solutions find traction in cost-conscious markets. Europe, the Middle East & Africa exhibit a dualistic pattern: Western Europe’s emphasis on clinical evidence drives investment in long-term observational studies and longitudinal meta analyses, whereas emerging markets in the Middle East and Africa show growing demand for ambulatory care devices that can function reliably within resource-constrained settings. Across Asia-Pacific, a surge in outpatient procedures and direct-to-consumer distribution channels has been fueled by expanding digital infrastructure, and governments are incentivizing local manufacturing of biodegradable and nanomaterial-based components to reduce import dependencies.

Key Company Insights in a Competitive and Innovative Space

The competitive landscape features a blend of established corporations and nimble innovators driving technological breakthroughs. Advanced Urology Solutions Inc. and UroFlex Systems Ltd. are at the forefront of minimally invasive device portfolios, integrating enhanced imaging integration with robotic assistance to reduce procedural times. BioMed Urology Corp. and UroInnovate Ltd. are capitalizing on biodegradable coatings and nanomaterial applications to improve biocompatibility profiles, while ProUro Surgical Inc. and MedTract Technologies, Inc. focus on endoscopic procedures augmented by laser ablation for calculi induced obstruction.

Digital integration has become a battleground: ClearFlow Medical Inc. and UroPulse Medical Technologies Inc. deploy artificial intelligence assistance in diagnostic platforms, streamlining patient triage and intervention planning. Robot-assisted systems from NexGen Urological Devices LLC and Streamline Urology Solutions Inc. are gaining FDA approvals, challenging legacy offerings. On the distribution front, UroLink Medical Systems Inc. and UroPrime Technologies Inc. extend e-commerce platforms with direct-to-consumer models, while hospital networks remain dominated by UroDynamic Systems Inc. and UroMedix Solutions Inc.

Emerging players such as TrueUro Technologies LLC, UroQuest Technologies Inc., and Quantum Urology Devices LLC are advancing clinical trial pipelines around adjunctive therapies and high-risk senior solutions. Meanwhile, premium option specialists like NovaUro Instruments Inc. and Precision Urologics Inc. leverage observational studies to validate efficacy, and budget friendly innovations from UroEdge Medical Inc. and UroPath Innovations Inc. stimulate broader market accessibility. Across this spectrum, collaboration between clinical evidence generators and device developers is accelerating the path from trials to approvals, ensuring that the most promising technologies reach patients faster.

Actionable Recommendations for Device Manufacturers and Stakeholders

Enhance collaboration between material scientists and device engineers to accelerate development of biodegradable and nanomaterial-based coatings that reduce infection rates and improve patient comfort. Integrate artificial intelligence assistance within digital imaging platforms to refine preoperative planning and real-time procedural guidance, thereby shortening learning curves and boosting surgical throughput. Prioritize outpatient and ambulatory care-compatible device designs to capture growth in non-hospital settings, reducing overall treatment costs and improving patient convenience. Establish modular manufacturing lines in tariff-exposed markets to mitigate trade-policy risks and ensure supply-chain resilience for critical components. Expand clinical trial networks in high-growth regions-particularly in the Middle East & Africa and Asia-Pacific-to generate region-specific real-world evidence and support local reimbursement pathways. Develop value based solutions with tiered pricing models that cater to budget conscious segments without compromising safety or efficacy. Foster strategic alliances with direct-to-consumer platforms to diversify distribution and improve market penetration in underserved areas.

Conclusion: Navigating Toward a Next-Generation Treatment Ecosystem

The urinary tract obstruction treatment device market stands at a pivotal juncture, characterized by technological convergence, policy-driven supply-chain realignments, and evolving care models. Organizations that embrace cross-functional innovation, from digital integration with artificial intelligence assistance to cutting-edge material science, will gain a competitive edge. Simultaneously, a proactive approach to regional regulatory environments and tariff contingencies will strengthen operational resilience. By aligning product design with the nuanced needs of adult, pediatric, and senior populations and optimizing for outpatient and ambulatory settings, manufacturers can unlock new revenue streams and improve patient outcomes. Ultimately, success hinges on the ability to translate clinical evidence into cost-effective, high-impact therapies that address the full spectrum of obstruction etiologies.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Device Technology
    • Customized Device Solutions
    • Innovative Materials
      • Biodegradable Coatings
      • Nanomaterial Applications
    • Minimally Invasive Solutions
  • Treatment Modality
    • Adjunctive Therapies
    • Non Surgical Procedures
      • Conservative Management
    • Surgical Methods
      • Endoscopic Procedures
      • Laser Ablation
  • Patient Demographics
    • Adult Treatments
    • Pediatric Treatments
    • Senior Treatments
      • High Risk Seniors
  • Obstruction Etiology
    • Benign Prostatic Hyperplasia
    • Calculi Induced Obstruction
    • Malignant Obstruction
      • Secondary Malignancies
  • Intervention Setting
    • Emergency Interventions
    • Inpatient Procedures
    • Outpatient Procedures
      • Ambulatory Care
  • Approval Status
    • Approved Devices
    • Clinical Trials
    • Pending Approval
  • Innovation Trends
    • Digital Integration
      • Artificial Intelligence Assistance
    • Enhanced Imaging Integration
    • Robotic Assistance
  • Distribution Channels
    • E Commerce Platforms
      • Direct To Consumer
    • Hospital Networks
    • Retail Clinics
  • Cost Analysis
    • Cost Effective Solutions
    • Premium Options
    • Value Based Solutions
      • Budget Friendly Innovations
  • Clinical Evidence
    • Meta Analysis
      • Longitudinal Studies
    • Observational Studies
    • Randomized Control Trials
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Advanced Urology Solutions Inc.
  • BioMed Urology Corp.
  • ClearFlow Medical Inc.
  • Elite Urology Instruments Inc.
  • Innovurology Ltd.
  • MedFlow Urological Inc.
  • MedTract Technologies, Inc.
  • MedUro Devices Ltd.
  • NexGen Urological Devices LLC
  • NovaUro Instruments Inc.
  • Precision Urologics Inc.
  • ProUro Surgical Inc.
  • Quantum Urology Devices LLC
  • SafeFlow Urology Technologies Inc.
  • Streamline Urology Solutions Inc.
  • TrueUro Technologies LLC
  • UroDynamic Systems Inc.
  • UroEdge Medical Inc.
  • UroFlex Systems Ltd.
  • UroInnovate Ltd.
  • UroLink Medical Systems Inc.
  • UroMatrix Corporation
  • UroMedix Solutions Inc.
  • UroPath Innovations Inc.
  • UroPrime Technologies Inc.
  • UroPulse Medical Technologies Inc.
  • UroQuest Technologies Inc.
  • UroSonic Technologies LLC
  • UroTech Devices LLC
  • UroVital Medical Devices Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Urinary Tract Obstruction Treatment Devices Market, by Device Technology
8.1. Introduction
8.2. Customized Device Solutions
8.3. Innovative Materials
8.3.1. Biodegradable Coatings
8.3.2. Nanomaterial Applications
8.4. Minimally Invasive Solutions
9. Urinary Tract Obstruction Treatment Devices Market, by Treatment Modality
9.1. Introduction
9.2. Adjunctive Therapies
9.3. Non Surgical Procedures
9.3.1. Conservative Management
9.4. Surgical Methods
9.4.1. Endoscopic Procedures
9.4.2. Laser Ablation
10. Urinary Tract Obstruction Treatment Devices Market, by Patient Demographics
10.1. Introduction
10.2. Adult Treatments
10.3. Pediatric Treatments
10.4. Senior Treatments
10.4.1. High Risk Seniors
11. Urinary Tract Obstruction Treatment Devices Market, by Obstruction Etiology
11.1. Introduction
11.2. Benign Prostatic Hyperplasia
11.3. Calculi Induced Obstruction
11.4. Malignant Obstruction
11.4.1. Secondary Malignancies
12. Urinary Tract Obstruction Treatment Devices Market, by Intervention Setting
12.1. Introduction
12.2. Emergency Interventions
12.3. Inpatient Procedures
12.4. Outpatient Procedures
12.4.1. Ambulatory Care
13. Urinary Tract Obstruction Treatment Devices Market, by Approval Status
13.1. Introduction
13.2. Approved Devices
13.3. Clinical Trials
13.4. Pending Approval
14. Urinary Tract Obstruction Treatment Devices Market, by Innovation Trends
14.1. Introduction
14.2. Digital Integration
14.2.1. Artificial Intelligence Assistance
14.3. Enhanced Imaging Integration
14.4. Robotic Assistance
15. Urinary Tract Obstruction Treatment Devices Market, by Distribution Channels
15.1. Introduction
15.2. E Commerce Platforms
15.2.1. Direct To Consumer
15.3. Hospital Networks
15.4. Retail Clinics
16. Urinary Tract Obstruction Treatment Devices Market, by Cost Analysis
16.1. Introduction
16.2. Cost Effective Solutions
16.3. Premium Options
16.4. Value Based Solutions
16.4.1. Budget Friendly Innovations
17. Urinary Tract Obstruction Treatment Devices Market, by Clinical Evidence
17.1. Introduction
17.2. Meta Analysis
17.2.1. Longitudinal Studies
17.3. Observational Studies
17.4. Randomized Control Trials
18. Americas Urinary Tract Obstruction Treatment Devices Market
18.1. Introduction
18.2. Argentina
18.3. Brazil
18.4. Canada
18.5. Mexico
18.6. United States
19. Asia-Pacific Urinary Tract Obstruction Treatment Devices Market
19.1. Introduction
19.2. Australia
19.3. China
19.4. India
19.5. Indonesia
19.6. Japan
19.7. Malaysia
19.8. Philippines
19.9. Singapore
19.10. South Korea
19.11. Taiwan
19.12. Thailand
19.13. Vietnam
20. Europe, Middle East & Africa Urinary Tract Obstruction Treatment Devices Market
20.1. Introduction
20.2. Denmark
20.3. Egypt
20.4. Finland
20.5. France
20.6. Germany
20.7. Israel
20.8. Italy
20.9. Netherlands
20.10. Nigeria
20.11. Norway
20.12. Poland
20.13. Qatar
20.14. Russia
20.15. Saudi Arabia
20.16. South Africa
20.17. Spain
20.18. Sweden
20.19. Switzerland
20.20. Turkey
20.21. United Arab Emirates
20.22. United Kingdom
21. Competitive Landscape
21.1. Market Share Analysis, 2024
21.2. FPNV Positioning Matrix, 2024
21.3. Competitive Analysis
21.3.1. Advanced Urology Solutions Inc.
21.3.2. BioMed Urology Corp.
21.3.3. ClearFlow Medical Inc.
21.3.4. Elite Urology Instruments Inc.
21.3.5. Innovurology Ltd.
21.3.6. MedFlow Urological Inc.
21.3.7. MedTract Technologies, Inc.
21.3.8. MedUro Devices Ltd.
21.3.9. NexGen Urological Devices LLC
21.3.10. NovaUro Instruments Inc.
21.3.11. Precision Urologics Inc.
21.3.12. ProUro Surgical Inc.
21.3.13. Quantum Urology Devices LLC
21.3.14. SafeFlow Urology Technologies Inc.
21.3.15. Streamline Urology Solutions Inc.
21.3.16. TrueUro Technologies LLC
21.3.17. UroDynamic Systems Inc.
21.3.18. UroEdge Medical Inc.
21.3.19. UroFlex Systems Ltd.
21.3.20. UroInnovate Ltd.
21.3.21. UroLink Medical Systems Inc.
21.3.22. UroMatrix Corporation
21.3.23. UroMedix Solutions Inc.
21.3.24. UroPath Innovations Inc.
21.3.25. UroPrime Technologies Inc.
21.3.26. UroPulse Medical Technologies Inc.
21.3.27. UroQuest Technologies Inc.
21.3.28. UroSonic Technologies LLC
21.3.29. UroTech Devices LLC
21.3.30. UroVital Medical Devices Inc.
22. ResearchAI
23. ResearchStatistics
24. ResearchContacts
25. ResearchArticles
26. Appendix
List of Figures
FIGURE 1. URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET MULTI-CURRENCY
FIGURE 2. URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DEVICE TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DEVICE TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY OBSTRUCTION ETIOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY OBSTRUCTION ETIOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INTERVENTION SETTING, 2024 VS 2030 (%)
FIGURE 16. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INTERVENTION SETTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY APPROVAL STATUS, 2024 VS 2030 (%)
FIGURE 18. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY APPROVAL STATUS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INNOVATION TRENDS, 2024 VS 2030 (%)
FIGURE 20. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INNOVATION TRENDS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024 VS 2030 (%)
FIGURE 22. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY COST ANALYSIS, 2024 VS 2030 (%)
FIGURE 24. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY COST ANALYSIS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY CLINICAL EVIDENCE, 2024 VS 2030 (%)
FIGURE 26. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY CLINICAL EVIDENCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. AMERICAS URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. AMERICAS URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. UNITED STATES URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 30. UNITED STATES URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. ASIA-PACIFIC URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 32. ASIA-PACIFIC URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 33. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 34. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 35. URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 36. URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DEVICE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY CUSTOMIZED DEVICE SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INNOVATIVE MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY BIODEGRADABLE COATINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY NANOMATERIAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INNOVATIVE MATERIALS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY ADJUNCTIVE THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY NON SURGICAL PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY CONSERVATIVE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY NON SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY SURGICAL METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY LASER ABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY SURGICAL METHODS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY ADULT TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY PEDIATRIC TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY SENIOR TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY HIGH RISK SENIORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY SENIOR TREATMENTS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY OBSTRUCTION ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY CALCULI INDUCED OBSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY MALIGNANT OBSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY SECONDARY MALIGNANCIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY MALIGNANT OBSTRUCTION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INTERVENTION SETTING, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY EMERGENCY INTERVENTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INPATIENT PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY OUTPATIENT PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY OUTPATIENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY APPROVAL STATUS, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY APPROVED DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY PENDING APPROVAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INNOVATION TRENDS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DIGITAL INTEGRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY ARTIFICIAL INTELLIGENCE ASSISTANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DIGITAL INTEGRATION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY ENHANCED IMAGING INTEGRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY ROBOTIC ASSISTANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DIRECT TO CONSUMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY HOSPITAL NETWORKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY RETAIL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY COST ANALYSIS, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY COST EFFECTIVE SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY PREMIUM OPTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY VALUE BASED SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY BUDGET FRIENDLY INNOVATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY VALUE BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY CLINICAL EVIDENCE, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY META ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY LONGITUDINAL STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY META ANALYSIS, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY OBSERVATIONAL STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY RANDOMIZED CONTROL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DEVICE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INNOVATIVE MATERIALS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY NON SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY SURGICAL METHODS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY SENIOR TREATMENTS, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY OBSTRUCTION ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY MALIGNANT OBSTRUCTION, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INTERVENTION SETTING, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY OUTPATIENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY APPROVAL STATUS, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INNOVATION TRENDS, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DIGITAL INTEGRATION, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY COST ANALYSIS, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY VALUE BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY CLINICAL EVIDENCE, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY META ANALYSIS, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DEVICE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INNOVATIVE MATERIALS, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY NON SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY SURGICAL METHODS, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY SENIOR TREATMENTS, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY OBSTRUCTION ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY MALIGNANT OBSTRUCTION, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INTERVENTION SETTING, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY OUTPATIENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY APPROVAL STATUS, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INNOVATION TRENDS, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DIGITAL INTEGRATION, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY COST ANALYSIS, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY VALUE BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY CLINICAL EVIDENCE, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY META ANALYSIS, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DEVICE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INNOVATIVE MATERIALS, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY NON SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY SURGICAL METHODS, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY SENIOR TREATMENTS, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY OBSTRUCTION ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY MALIGNANT OBSTRUCTION, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INTERVENTION SETTING, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY OUTPATIENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY APPROVAL STATUS, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INNOVATION TRENDS, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DIGITAL INTEGRATION, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY COST ANALYSIS, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY VALUE BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY CLINICAL EVIDENCE, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY META ANALYSIS, 2018-2030 (USD MILLION)
TABLE 129. CANADA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DEVICE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 130. CANADA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INNOVATIVE MATERIALS, 2018-2030 (USD MILLION)
TABLE 131. CANADA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 132. CANADA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY NON SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 133. CANADA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY SURGICAL METHODS, 2018-2030 (USD MILLION)
TABLE 134. CANADA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 135. CANADA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY SENIOR TREATMENTS, 2018-2030 (USD MILLION)
TABLE 136. CANADA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY OBSTRUCTION ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 137. CANADA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY MALIGNANT OBSTRUCTION, 2018-2030 (USD MILLION)
TABLE 138. CANADA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INTERVENTION SETTING, 2018-2030 (USD MILLION)
TABLE 139. CANADA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY OUTPATIENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 140. CANADA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY APPROVAL STATUS, 2018-2030 (USD MILLION)
TABLE 141. CANADA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INNOVATION TRENDS, 2018-2030 (USD MILLION)
TABLE 142. CANADA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DIGITAL INTEGRATION, 2018-2030 (USD MILLION)
TABLE 143. CANADA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 144. CANADA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 145. CANADA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY COST ANALYSIS, 2018-2030 (USD MILLION)
TABLE 146. CANADA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY VALUE BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 147. CANADA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY CLINICAL EVIDENCE, 2018-2030 (USD MILLION)
TABLE 148. CANADA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY META ANALYSIS, 2018-2030 (USD MILLION)
TABLE 149. MEXICO URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DEVICE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 150. MEXICO URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INNOVATIVE MATERIALS, 2018-2030 (USD MILLION)
TABLE 151. MEXICO URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 152. MEXICO URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY NON SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 153. MEXICO URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY SURGICAL METHODS, 2018-2030 (USD MILLION)
TABLE 154. MEXICO URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 155. MEXICO URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY SENIOR TREATMENTS, 2018-2030 (USD MILLION)
TABLE 156. MEXICO URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY OBSTRUCTION ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 157. MEXICO URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY MALIGNANT OBSTRUCTION, 2018-2030 (USD MILLION)
TABLE 158. MEXICO URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INTERVENTION SETTING, 2018-2030 (USD MILLION)
TABLE 159. MEXICO URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY OUTPATIENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 160. MEXICO URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY APPROVAL STATUS, 2018-2030 (USD MILLION)
TABLE 161. MEXICO URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INNOVATION TRENDS, 2018-2030 (USD MILLION)
TABLE 162. MEXICO URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DIGITAL INTEGRATION, 2018-2030 (USD MILLION)
TABLE 163. MEXICO URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 164. MEXICO URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 165. MEXICO URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY COST ANALYSIS, 2018-2030 (USD MILLION)
TABLE 166. MEXICO URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY VALUE BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 167. MEXICO URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY CLINICAL EVIDENCE, 2018-2030 (USD MILLION)
TABLE 168. MEXICO URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY META ANALYSIS, 2018-2030 (USD MILLION)
TABLE 169. UNITED STATES URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DEVICE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 170. UNITED STATES URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INNOVATIVE MATERIALS, 2018-2030 (USD MILLION)
TABLE 171. UNITED STATES URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 172. UNITED STATES URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY NON SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 173. UNITED STATES URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY SURGICAL METHODS, 2018-2030 (USD MILLION)
TABLE 174. UNITED STATES URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 175. UNITED STATES URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY SENIOR TREATMENTS, 2018-2030 (USD MILLION)
TABLE 176. UNITED STATES URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY OBSTRUCTION ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 177. UNITED STATES URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY MALIGNANT OBSTRUCTION, 2018-2030 (USD MILLION)
TABLE 178. UNITED STATES URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INTERVENTION SETTING, 2018-2030 (USD MILLION)
TABLE 179. UNITED STATES URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY OUTPATIENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 180. UNITED STATES URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY APPROVAL STATUS, 2018-2030 (USD MILLION)
TABLE 181. UNITED STATES URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INNOVATION TRENDS, 2018-2030 (USD MILLION)
TABLE 182. UNITED STATES URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DIGITAL INTEGRATION, 2018-2030 (USD MILLION)
TABLE 183. UNITED STATES URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 184. UNITED STATES URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 185. UNITED STATES URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY COST ANALYSIS, 2018-2030 (USD MILLION)
TABLE 186. UNITED STATES URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY VALUE BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 187. UNITED STATES URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY CLINICAL EVIDENCE, 2018-2030 (USD MILLION)
TABLE 188. UNITED STATES URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY META ANALYSIS, 2018-2030 (USD MILLION)
TABLE 189. UNITED STATES URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 190. ASIA-PACIFIC URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DEVICE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. ASIA-PACIFIC URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INNOVATIVE MATERIALS, 2018-2030 (USD MILLION)
TABLE 192. ASIA-PACIFIC URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 193. ASIA-PACIFIC URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY NON SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 194. ASIA-PACIFIC URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY SURGICAL METHODS, 2018-2030 (USD MILLION)
TABLE 195. ASIA-PACIFIC URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 196. ASIA-PACIFIC URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY SENIOR TREATMENTS, 2018-2030 (USD MILLION)
TABLE 197. ASIA-PACIFIC URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY OBSTRUCTION ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY MALIGNANT OBSTRUCTION, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INTERVENTION SETTING, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY OUTPATIENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY APPROVAL STATUS, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INNOVATION TRENDS, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DIGITAL INTEGRATION, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY COST ANALYSIS, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY VALUE BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY CLINICAL EVIDENCE, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY META ANALYSIS, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 211. AUSTRALIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DEVICE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 212. AUSTRALIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INNOVATIVE MATERIALS, 2018-2030 (USD MILLION)
TABLE 213. AUSTRALIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 214. AUSTRALIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY NON SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 215. AUSTRALIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY SURGICAL METHODS, 2018-2030 (USD MILLION)
TABLE 216. AUSTRALIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 217. AUSTRALIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY SENIOR TREATMENTS, 2018-2030 (USD MILLION)
TABLE 218. AUSTRALIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY OBSTRUCTION ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 219. AUSTRALIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY MALIGNANT OBSTRUCTION, 2018-2030 (USD MILLION)
TABLE 220. AUSTRALIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INTERVENTION SETTING, 2018-2030 (USD MILLION)
TABLE 221. AUSTRALIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY OUTPATIENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 222. AUSTRALIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY APPROVAL STATUS, 2018-2030 (USD MILLION)
TABLE 223. AUSTRALIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INNOVATION TRENDS, 2018-2030 (USD MILLION)
TABLE 224. AUSTRALIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DIGITAL INTEGRATION, 2018-2030 (USD MILLION)
TABLE 225. AUSTRALIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY COST ANALYSIS, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY VALUE BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY CLINICAL EVIDENCE, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY META ANALYSIS, 2018-2030 (USD MILLION)
TABLE 231. CHINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DEVICE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 232. CHINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INNOVATIVE MATERIALS, 2018-2030 (USD MILLION)
TABLE 233. CHINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 234. CHINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY NON SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 235. CHINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY SURGICAL METHODS, 2018-2030 (USD MILLION)
TABLE 236. CHINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 237. CHINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY SENIOR TREATMENTS, 2018-2030 (USD MILLION)
TABLE 238. CHINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY OBSTRUCTION ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 239. CHINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY MALIGNANT OBSTRUCTION, 2018-2030 (USD MILLION)
TABLE 240. CHINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INTERVENTION SETTING, 2018-2030 (USD MILLION)
TABLE 241. CHINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY OUTPATIENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 242. CHINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY APPROVAL STATUS, 2018-2030 (USD MILLION)
TABLE 243. CHINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INNOVATION TRENDS, 2018-2030 (USD MILLION)
TABLE 244. CHINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DIGITAL INTEGRATION, 2018-2030 (USD MILLION)
TABLE 245. CHINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 246. CHINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 247. CHINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY COST ANALYSIS, 2018-2030 (USD MILLION)
TABLE 248. CHINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY VALUE BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 249. CHINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY CLINICAL EVIDENCE, 2018-2030 (USD MILLION)
TABLE 250. CHINA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY META ANALYSIS, 2018-2030 (USD MILLION)
TABLE 251. INDIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY DEVICE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 252. INDIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INNOVATIVE MATERIALS, 2018-2030 (USD MILLION)
TABLE 253. INDIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 254. INDIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY NON SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 255. INDIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY SURGICAL METHODS, 2018-2030 (USD MILLION)
TABLE 256. INDIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 257. INDIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY SENIOR TREATMENTS, 2018-2030 (USD MILLION)
TABLE 258. INDIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY OBSTRUCTION ETIOLOGY, 2018-2030 (USD MILLION)
TABLE 259. INDIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY MALIGNANT OBSTRUCTION, 2018-2030 (USD MILLION)
TABLE 260. INDIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY INTERVENTION SETTING, 2018-2030 (USD MILLION)
TABLE 261. INDIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY OUTPATIENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 262. INDIA URINARY TRACT OBSTRUCTION TREATMENT DEVICES MARKET SIZE, BY APPROVAL STATUS, 2018-2030 (USD MILLION)
TABLE 263. IN

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Urinary Tract Obstruction Treatment Devices market report include:
  • Advanced Urology Solutions Inc.
  • BioMed Urology Corp.
  • ClearFlow Medical Inc.
  • Elite Urology Instruments Inc.
  • Innovurology Ltd.
  • MedFlow Urological Inc.
  • MedTract Technologies, Inc.
  • MedUro Devices Ltd.
  • NexGen Urological Devices LLC
  • NovaUro Instruments Inc.
  • Precision Urologics Inc.
  • ProUro Surgical Inc.
  • Quantum Urology Devices LLC
  • SafeFlow Urology Technologies Inc.
  • Streamline Urology Solutions Inc.
  • TrueUro Technologies LLC
  • UroDynamic Systems Inc.
  • UroEdge Medical Inc.
  • UroFlex Systems Ltd.
  • UroInnovate Ltd.
  • UroLink Medical Systems Inc.
  • UroMatrix Corporation
  • UroMedix Solutions Inc.
  • UroPath Innovations Inc.
  • UroPrime Technologies Inc.
  • UroPulse Medical Technologies Inc.
  • UroQuest Technologies Inc.
  • UroSonic Technologies LLC
  • UroTech Devices LLC
  • UroVital Medical Devices Inc.

Related Topics

Related Reports

Urinary Tract Obstruction Treatment Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Urinary Tract Obstruction Treatment Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Urinary Tract Obstruction Treatment Devices Market Report 2025 - Product Image

Urinary Tract Obstruction Treatment Devices Market Report 2025

  • Report
  • 175 Pages
  • Global
From
India Urology Device - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

India Urology Device - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 120 Pages
  • India
From
Benign Prostatic Hyperplasia (BPH) Treatment Devices and Equipment Market Report 2025 - Product Image

Benign Prostatic Hyperplasia (BPH) Treatment Devices and Equipment Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Tertiary Dilation Balloon Catheters - Global Strategic Business Report - Product Image

Tertiary Dilation Balloon Catheters - Global Strategic Business Report

  • Report
  • 368 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.